Lupin Buys Stake in Japan Firm

Pharma company Lupin Ltd. (Mumbai) says that it has acquired a majority stake in generics pharmaceutical manufacturer Kyowa Pharmaceutical Industry Co. Ltd. (Osaka), for an undisclosed amount. Lupin is rumored to have paid about $60 million for the firm, reports say. “This is a very significant part of our strategy to tap leading global markets, and [the deal] establishes a beachhead [for Lupin] in the second-largest pharmaceutical market in the world,” says Desh Bandhu Gupta, Lupin chairman. “Kyowa has major strengths in product development...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers